Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03692429
Brief Title: alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (alloSHRINK)

First Submitted : August 31, 2018
First Submitted that Met QC Criteria : October 1, 2018
First Posted : October 2, 2018

Last Update Submitted that Met QC Criteria : November 19, 2019
Last Update Posted : November 20, 2019